The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion

Schlomann U, Wildeboer D, Webster A, Antropova O, Zeuschner D, Knight CG, Docherty AJP, Lambert M, Skelton L, Jockusch H, Bartsch JW (2002)
Journal of Biological Chemistry 277(50): 48210-48219.

Download
No fulltext has been uploaded. References only!
Journal Article | Original Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ; ; ; ;
Abstract
ADAMs (a disintegrin and metalloprotease domains) are metalloprotease and disintegrin domain-containing transmembrane glycoproteins with proteolytic, cell adhesion, cell fusion, and cell signaling properties. ADAM8 was originally cloned from monocytic cells, and its distinct expression pattern indicates possible roles in both immunology and neuropathology. Here we describe our analysis of its biochemical properties. In transfected COS-7 cells, ADAM8 is localized to the plasma membrane and processed into two forms derived either by prodomain removal or as remnant protein comprising the extracellular region with the disintegrin domain at the N terminus. Proteolytic removal of the ADAM8 propeptide was completely blocked in mutant ADAM8 with a Glu(330) to Gln exchange (EQ-A8) in the Zn2+ binding motif (HE(330)LGHNLGMSHD), arguing for autocatalytic prodomain removal. In co-transfection experiments, the ectodomain but not the entire MP domain of ADAM8 was able to remove the prodomain from EQ-ADAM8. With cells expressing ADAM8, cell adhesion to a substrate-bound recombinant ADAM8 disintegrin/Cys-rich domain was observed in the absence of serum, blocked by an antibody directed against the ADAM8 disintegrin domain. Soluble ADAM8 protease, consisting of either the metalloprotease domain or the complete ectodomain, cleaved myelin basic protein and a fluorogenic peptide substrate, and was inhibited by batimastat (BB-94, IC50 similar to50 nM) but not by recombinant tissue inhibitor of matrix metalloproteinases 1, 2, 3, and 4. Our findings demonstrate that ADAM8 processing by autocatalysis leads to a potential sheddase and to a form of ADAM8 with a function in cell adhesion.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Schlomann U, Wildeboer D, Webster A, et al. The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion. Journal of Biological Chemistry. 2002;277(50):48210-48219.
Schlomann, U., Wildeboer, D., Webster, A., Antropova, O., Zeuschner, D., Knight, C. G., Docherty, A. J. P., et al. (2002). The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion. Journal of Biological Chemistry, 277(50), 48210-48219. doi:10.1074/jbc.M203355200
Schlomann, U., Wildeboer, D., Webster, A., Antropova, O., Zeuschner, D., Knight, C. G., Docherty, A. J. P., Lambert, M., Skelton, L., Jockusch, H., et al. (2002). The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion. Journal of Biological Chemistry 277, 48210-48219.
Schlomann, U., et al., 2002. The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion. Journal of Biological Chemistry, 277(50), p 48210-48219.
U. Schlomann, et al., “The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion”, Journal of Biological Chemistry, vol. 277, 2002, pp. 48210-48219.
Schlomann, U., Wildeboer, D., Webster, A., Antropova, O., Zeuschner, D., Knight, C.G., Docherty, A.J.P., Lambert, M., Skelton, L., Jockusch, H., Bartsch, J.W.: The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion. Journal of Biological Chemistry. 277, 48210-48219 (2002).
Schlomann, U, Wildeboer, D, Webster, A, Antropova, O, Zeuschner, D, Knight, CG, Docherty, AJP, Lambert, M, Skelton, L, Jockusch, Harald, and Bartsch, JW. “The metalloprotease disintegrin ADAM8 - Processing by autocatalysis is required for proteolytic activity and cell adhesion”. Journal of Biological Chemistry 277.50 (2002): 48210-48219.
This data publication is cited in the following publications:
This publication cites the following data publications:

68 Citations in Europe PMC

Data provided by Europe PubMed Central.

IL-5-stimulated eosinophils adherent to periostin undergo stereotypic morphological changes and ADAM8-dependent migration.
Johansson MW, Khanna M, Bortnov V, Annis DS, Nguyen CL, Mosher DF., Clin. Exp. Allergy 47(10), 2017
PMID: 28378503
SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.
Tien WS, Chen JH, Wu KP., BMC Bioinformatics 18(Suppl 3), 2017
PMID: 28361715
Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases.
Dreymueller D, Theodorou K, Donners M, Ludwig A., Mediators Inflamm. 2017(), 2017
PMID: 28260841
Processing of Snake Venom Metalloproteinases: Generation of Toxin Diversity and Enzyme Inactivation.
Moura-da-Silva AM, Almeida MT, Portes-Junior JA, Nicolau CA, Gomes-Neto F, Valente RH., Toxins (Basel) 8(6), 2016
PMID: 27294958
miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.
Das SG, Romagnoli M, Mineva ND, Barille-Nion S, Jezequel P, Campone M, Sonenshein GE., Breast Cancer Res. 18(1), 2016
PMID: 27039296
N-glycosylation regulates ADAM8 processing and activation.
Srinivasan S, Romagnoli M, Bohm A, Sonenshein GE., J. Biol. Chem. 289(48), 2014
PMID: 25336660
ADAM8 in asthma. Friend or foe to airway inflammation?
Chen J, Jiang X, Duan Y, Long J, Bartsch JW, Deng L., Am. J. Respir. Cell Mol. Biol. 49(6), 2013
PMID: 23837412
ADAMDEC1 is a metzincin metalloprotease with dampened proteolytic activity.
Lund J, Olsen OH, Sorensen ES, Stennicke HR, Petersen HH, Overgaard MT., J. Biol. Chem. 288(29), 2013
PMID: 23754285
High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
Zhang Y, Tan YF, Jiang C, Zhang K, Zha TZ, Zhang M., Pathol. Oncol. Res. 19(1), 2013
PMID: 22965687
High expression of ADAM8 correlates with poor prognosis in hepatocellular carcinoma.
Zhang Y, Zha TZ, Hu BS, Jiang C, Ge ZJ, Zhang K, Tan YF., Surgeon 11(2), 2013
PMID: 22878099
Elevated levels of a disintegrin and metalloproteinase 8 in gingival crevicular fluid of patients with periodontal diseases.
Khongkhunthian S, Techasatian P, Supanchart C, Bandhaya P, Montreekachon P, Thawanaphong S, Krisanaprakornkit S., J. Periodontol. 84(4), 2013
PMID: 22612366
Expression of ADAM8 and its clinical values in diagnosis and prognosis of hepatocellular carcinoma.
Jiang C, Zhang Y, Yu HF, Yu XT, Zhou SJ, Tan YF., Tumour Biol. 33(6), 2012
PMID: 22941466
Deficiency of the metalloproteinase-disintegrin ADAM8 is associated with thymic hyper-cellularity.
Gossens K, Naus S, Hollander GA, Ziltener HJ., PLoS ONE 5(9), 2010
PMID: 20856819
ADAM8 substrate specificity: influence of pH on pre-processing and proteoglycan degradation.
Hall T, Pegg LE, Pauley AM, Fischer HD, Tomasselli AG, Zack MD., Arch. Biochem. Biophys. 491(1-2), 2009
PMID: 19766586
Reduced incidence and severity of experimental autoimmune arthritis in mice expressing catalytically inactive A disintegrin and metalloproteinase 8 (ADAM8).
Zack MD, Melton MA, Stock JL, Storer CE, Barve RA, Minnerly JC, Weiss DJ, Stejskal JA, Tortorella MD, Turk JR, Shevlin KM, Malfait AM., Clin. Exp. Immunol. 158(2), 2009
PMID: 19737139

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 12372841
PubMed | Europe PMC

Search this title in

Google Scholar